Remedent (REMI) Stock Price, News & Analysis

Company Overview

Remedent, Inc. researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products in the United States and internationally. It primarily provides professional veneers and teeth whitening products for professional and over-the-counter use. The company also offers River8, a prefab veneer that enables the dentist to find the right combination of teeth for a patient with minor reshaping. In addition, it provides GlamSmile veneers, which are ultra-thin claddings attached to the front of the patient's teeth. Further, the company offers SmileMe Mirror, an integrated marketing concept for the dental practice that enables dentists to offer smile consultation in approximately 10 minutes; SmileSketch, a simulation software to make a sketch of what the patient could look like; and various Treatment Pages to explain the benefits of certain treatments, as well as Condor, an intra-oral 3D scanner. Additionally, it provides dental implant solutions and treatment concepts. The company sells its products through internal sales force and third party distributors. Remedent, Inc. was incorporated in 1986 and is headquartered in Ghent, Belgium.

Key Stats

• Today's Range: $0.05 to $0.05
• 50-Day Range: $0.05 to $0.06
• 52-Week Range: $0.02 to $0.08
• Volume: N/A
• Average Volume: 2,000 shs
• Market Capitalization: $1 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

REMI Stock Analysis - Frequently Asked Questions

How have REMI shares performed this year?

Remedent's stock was trading at $0.0550 at the beginning of 2025. Since then, REMI stock has decreased by 9.1% and is now trading at $0.05.
View the best growth stocks for 2025 here.

How do I buy shares of Remedent?

Shares of REMI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Remedent own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Remedent investors own include AbbVie (ABBV), CoStar Group (CSGP), Enterprise Products Partners (EPD), Kellanova (K), Kandi Technologies Group (KNDI), MKS Instruments (MKSI) and M&T Bank (MTB).

Company Calendar

• Today: 2/22/2025
• Fiscal Year End: 3/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Dental equipment & supplies
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:REMI
• CUSIP: N/A
• CIK: 1078037
• Web: www.remedent.com
• Phone: (329) 241-5880
• Fax: 329-241-5899
• Employees: 4
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $990,000.00
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: $1 million
• Optionable: Not Optionable
• Beta: -0.04